Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy

Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy

Background: Limited evidence exists on the impact of adding a taxane, using endocrine therapy and carrying a deleterious germline BRCA mutation on ovarian reserve measured by anti-müllerian hormone (AMH) levels of young breast cancer patients receiving (neo)adjuvant cyclophosphamide- and anthracycli...

Full description

Bibliographic Details
Main Authors: Matteo Lambertini, Nathalie Olympios, Justine Lequesne, Céline Calbrix, Maxime Fontanilles, Agnès Loeb, Marianne Leheurteur, Isabelle Demeestere, Frédéric Di Fiore, Anne Perdrix, Florian Clatot
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Oncology
Subjects:
breast cancer
AMH
taxane
endocrine therapy
BRCA mutations
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00575/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00575/full

Similar Items